Publication information
About Microdose Margin
A publication for the details that a headline cannot settle.
Our focus
Microdose Margin examines public records around advertised tirzepatide microdosing programs. A provider description, price card, safety-report count and clinical trial each supports a different kind of statement. Our articles keep those differences visible.
The margin has a purpose
The document reader places supported statements beside unsupported inferences and unresolved details. Its fixed examples invite careful reading. They do not determine a diagnosis, clinical risk, appropriate prescription or individual financial obligation.
Our publishing relationship
This site is part of the CoreAge Rx promotional publishing network. CoreAge receives the first commercial placement. The coverage is editorial source research, without claimed patient experience, provider testing, clinician sign-off or a finding of clinical superiority.